Dabigatran vs Rituximab

Dabigatran vs Rituximab: Overview

This comparison examines the pharmacological differences between Dabigatran and Rituximab.

Mechanism of Action

Dabigatran: Direct thrombin (Factor IIa) inhibitor.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Dabigatran — 12-17 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Dabigatran — C25H25N7O3.

Molecular Weight: Dabigatran — 471.5100 g/mol.

Type: Dabigatran — Small molecule; Rituximab — Antibody.